These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 29550056)

  • 1. Corrigendum to "Therapeutic Effectiveness and Tolerability of Aripiprazole as Initial Choice of Treatment in First Episode Psychosis in an Early Intervention Service: A One-Year Outcome Study" [Schizophr. Res. 147, 120-125].
    Malla A; Mustafa S; Rho A; Abadi S; Lepage M; Joober R
    Schizophr Res; 2018 Mar; 193():490. PubMed ID: 29550056
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic effectiveness and tolerability of aripiprazole as initial choice of treatment in first episode psychosis in an early intervention service: A one-year outcome study.
    Malla A; Mustafa S; Rho A; Abadi S; Lepage M; Joober R
    Schizophr Res; 2016 Jul; 174(1-3):120-125. PubMed ID: 27157800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum to "abnormal white matter integrity in antipsychotic-naïve first-episode psychosis patients assessed by a DTI principal component analysis" [Schizophr. Res. 162 (1-3) (march 2015) 14-21].
    Alvarado-Alanis P; León-Ortiz P; Reyes-Madrigal F; Favila R; Rodríguez-Mayoral O; Nicolini H; Azcárraga M; Graff-Guerrero A; Rowland LM; de la Fuente-Sandoval C
    Schizophr Res; 2016 Oct; 176(2-3):582. PubMed ID: 27264503
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to "Cognitive performance at first episode of psychosis and the relationship with future treatment resistance: Evidence from an international prospective cohort study" [Schizophr. Res. volume 225 (May 2023) 173-181].
    Millgate E; Smart SE; Pardiñas AF; Kravariti E; Ajnakina O; Kępińska AP; Andreassen OA; Barnes TRE; Berardi D; Crespo-Facorro B; D'Andrea G; Demjaha A; Di Forti M; Doody GA; Üçok A; Kassoumeri L; Ferchiou A; Guidi L; Joyce EM; Lastrina O; Melle I; Pignon B; Richard JR; Simonsen C; Szöke A; Tarricone I; Tortelli A; Vázquez-Bourgon J; Murray RM; Walters JTR; MacCabe JH;
    Schizophr Res; 2024 Aug; 270():495-496. PubMed ID: 39079354
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "Neuroanatomical correlates of perceptual aberrations in psychosis" [Schizophr. Res. 179 (2017) 125-131].
    Brosey EA; Woodward ND
    Schizophr Res; 2018 Jul; 197():624. PubMed ID: 29699896
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to "self-reported cannabis use is inconsistent with the results from drug-screening in youth at ultra high-risk for psychosis in Colorado" [Schizophr. Res. 157 (0) (August 2014) 317-318].
    Carol EE; Mittal VA
    Schizophr Res; 2018 Feb; 192():494. PubMed ID: 28476338
    [No Abstract]   [Full Text] [Related]  

  • 7. Estimating the Cost and Effect of Early Intervention on In-Patient Admission in First Episode Psychosis.
    Behan C; Cullinan J; Kennelly B; Turner N; Owens E; Lau A; Kinsella A; Clarke M
    J Ment Health Policy Econ; 2015 Jun; 18(2):57-61. PubMed ID: 26231001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial predictors of outcome in an early intervention in psychosis service.
    Harrington E; Neffgen M; Sasalu P; Sehgal T; Woolley J
    Early Interv Psychiatry; 2013 Aug; 7(3):311-4. PubMed ID: 23342997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aripiprazole, Ziprasidone and Quetiapine in the treatment of first-episode nonaffective psychosis: a 12-week randomized, flexible-dose, open-label trial.
    Crespo-Facorro B; Ortiz-García de la Foz V; Mata I; Ayesa-Arriola R; Suarez-Pinilla P; Valdizan EM; Vázquez-Barquero JL; Pérez-Iglesias R
    Schizophr Res; 2013 Jul; 147(2-3):375-82. PubMed ID: 23643328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aripiprazole for drug-naive or antipsychotic-short-exposure subjects with ultra-high risk state and first-episode psychosis: an open-label study.
    Liu CC; Chien YL; Hsieh MH; Hwang TJ; Hwu HG; Liu CM
    J Clin Psychopharmacol; 2013 Feb; 33(1):18-23. PubMed ID: 23277261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of the BiRmingham Early Detection In untREated psyChosis Trial (REDIRECT): cluster randomised controlled trial of general practitioner education in detection of first episode psychosis [ISRCTN87898421].
    Tait L; Lester H; Birchwood M; Freemantle N; Wilson S
    BMC Health Serv Res; 2005 Mar; 5(1):19. PubMed ID: 15755321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical effectiveness in first-episode patients.
    Ohlsen RI; O'Toole MS; Purvis RG; Walters JT; Taylor TM; Jones HM; Pilowsky LS
    Eur Neuropsychopharmacol; 2004 Nov; 14 Suppl 4():S445-51. PubMed ID: 15572263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An exploration of what service users value about early intervention in psychosis services.
    Barr K; Ormrod J; Dudley R
    Psychol Psychother; 2015 Dec; 88(4):468-80. PubMed ID: 25572755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Lambeth Early Onset Crisis Assessment Team Study: general practitioner education and access to an early detection team in first-episode psychosis.
    Power P; Iacoponi E; Reynolds N; Fisher H; Russell M; Garety P; McGuire PK; Craig T
    Br J Psychiatry Suppl; 2007 Dec; 51():s133-9. PubMed ID: 18055931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention.
    Francey SM; Nelson B; Thompson A; Parker AG; Kerr M; Macneil C; Fraser R; Hughes F; Crisp K; Harrigan S; Wood SJ; Berk M; McGorry PD
    Schizophr Res; 2010 Jun; 119(1-3):1-10. PubMed ID: 20347270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corrigendum to "Long-term course of negative symptom subdomains and relationship with outcome in patients with a psychotic disorder" [Schizophr. Res. 193 (2018) 173-181].
    Stiekema APM; Islam MA; Liemburg EJ; Castelein S; van den Heuvel ER; van Weeghel J; Aleman A; Bruggeman R; van der Meer L; ; Alizadeh BZ; Bartels-Velthuis AA; van Beveren NJ; Bruggeman R; Cahn W; de Haan L; Delespaul P; Meijer CJ; Myin-Germeys I; Kahn RS; Schirmbeck F; Simons CJP; van Haren NEM; van Os J; van Winkel R
    Schizophr Res; 2019 Feb; 204():462-463. PubMed ID: 30314649
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "Facial, vocal and cross-modal emotion processing in early-onset schizophrenia spectrum disorder" [Schizophr. Res. (Aug. 18, 2015) pii: S0920-9964(15)00405-3. doi: 10. 1016/j.schres.2015.07.039].
    M G; J X; A F; N B; C L; D C; L C
    Schizophr Res; 2015 Dec; 169(1-3):508. PubMed ID: 28760563
    [No Abstract]   [Full Text] [Related]  

  • 18. The development and implementation of a pilot CBT for early psychosis service: achievements and challenges.
    Perry Y; Murrihy RC; Varlow M; Dedousis-Wallace A; Ellis DM; Langdon R; Kidman AD
    Early Interv Psychiatry; 2015 Jun; 9(3):252-9. PubMed ID: 24739251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aripiprazole-Induced Hypoprolactinemia in an Adult Male with First-Episode Psychosis.
    Propst AJ; Jarvis GE; Margolese HC
    Clin Schizophr Relat Psychoses; 2016; 9(4):173-6. PubMed ID: 25711510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Corrigendum to cytochrome P450 genotypes are not associated with refractoriness to antipsychotic treatment [Schizophr. Res. 168 (2015) 587-588].
    van de Bilt MT; Prado CM; Ojopi EPB; de Sousa RT; Loch AA; Zanetti MV; Talib LL; Gattaz WF
    Schizophr Res; 2016 Jul; 174(1-3):204. PubMed ID: 27066861
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.